• Health & Medicine

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer. A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

4 June 2016

• Health & Medicine

Let the right ones in – boosting immunotherapy for pancreatic cancer

Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences. Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences.

2 June 2016

• Health & Medicine

Scientists tear down pancreatic cancer's defences

Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs. Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.

2 June 2016

• Health & Medicine
• Science & Technology

Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres

We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor. We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.

13 May 2016

• Health & Medicine
• Science & Technology

More pieces of the jigsaw fall into place at the 2016 AACR Conference

We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans

6 May 2016

• Health & Medicine

Studies show continued promise for immunotherapy drugs

Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference. Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.

19 April 2016

• Science & Technology
• Health & Medicine

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

15 April 2016

• Health & Medicine

Gene editing could stop cancer cells escaping the immune system

Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy the disease. Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy the disease.

15 April 2016

• Health & Medicine
• Science & Technology

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer. An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

6 April 2016

• Health & Medicine
• Science & Technology

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples. We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

15 March 2016

• Health & Medicine
• Science & Technology

Cancer ‘master control switch’ could help tumours hide from immune system

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system. Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

11 March 2016